trial · primary record
TOL2506
Breast Cancer
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 250 |
| Primary completion | 2027-01-30 |
| Primary endpoint | Suppression of ovarian function |
| Registry ID | NCT04906395 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:56.649Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04906395
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.